Fratricide resistant modified immune cells and methods of using the same
Grant
US12576151B2
Kind: B2
Mar 17, 2026
Assignee
Beam Therapeutics Inc.
Inventors
Jason Gehrke
Abstract
The present invention features fratricide resistant modified immune cells (e.g., T- or NK-cells) having enhanced anti-neoplasia activity and methods for producing and using the same. Methods of treating neoplasia (e.g., T- or NK-cell malignancies) using fratricide resistant modified immune cells are also provided.
CPC Classifications
A61K 40/4224
Filing Date
2021-09-24
Application No.
18246656
Claims
8